Joe, looks like they dropped the AFPL version a couple of versions ago.

The last two were strictly GPL.

Charles Wilt
Software Engineer
CINTAS Corporation - IT 92B


-----Original Message-----
From: midrange-l-bounces@xxxxxxxxxxxx [mailto:midrange-l-
bounces@xxxxxxxxxxxx] On Behalf Of Joe Pluta
Sent: Thursday, March 13, 2008 10:40 AM
To: Midrange Systems Technical Discussion
Subject: Re: Cool iNav stuff was: Elimination of PDM/SEU in favor of

Wilt, Charles wrote:
Or you could save yourself $9.95 and use PDFCreator.

Open source, GPL License.

Errr... not quite. There is a GPL version and a newer AFPL version,
IIRC. AFPL disallows distribution in a commercial product.

And with ALL of these tools, please make sure to test them thoroughly.
Some work flawlessly, others have quirks that only show up when you try
to open it on a Windows 95 computer running Acrobat V3.

This is the Midrange Systems Technical Discussion (MIDRANGE-L) mailing
To post a message email: MIDRANGE-L@xxxxxxxxxxxx
To subscribe, unsubscribe, or change list options,
or email: MIDRANGE-L-request@xxxxxxxxxxxx
Before posting, please take a moment to review the archives

This e-mail transmission contains information that is intended to be confidential and privileged. If you receive this e-mail and you are not a named addressee you are hereby notified that you are not authorized to read, print, retain, copy or disseminate this communication without the consent of the sender and that doing so is prohibited and may be unlawful. Please reply to the message immediately by informing the sender that the message was misdirected. After replying, please delete and otherwise erase it and any attachments from your computer system. Your assistance in correcting this error is appreciated.

This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].